Imatinib mesylate (Gleevec(TM)) reduces phlebotomy requirements in polycythemia vera. uri icon

Overview

publication date

  • June 1, 2003

Research

keywords

  • Enzyme Inhibitors
  • Phlebotomy
  • Piperazines
  • Polycythemia Vera
  • Pyrimidines

Identity

Scopus Document Identifier

  • 0038717050

Digital Object Identifier (DOI)

  • 10.1038/sj.leu.2402938

PubMed ID

  • 12764388

Additional Document Info

volume

  • 17

issue

  • 6